Published in Health and Medicine Week, December 19th, 2005
"Cholera toxin B subunit (CT-B) is a powerful modulator of immune responses. [We] have previously demonstrated that oral administration of recombinant CT-B (rCT-B) is able to prevent and cure the Crohn disease (CD)-like trinitrobenzene sulfonic acid (TNBS) mediated colitis," researchers in Italy report.
According to E.M. Coccia and colleagues at the Istituto Superiore di Sanita in Rome, "In this study [we] extended [these] observations and examined if rCT-B interferes with the molecular signaling underlying the Th1 type response both in TNBS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.